HomeTrialNCT07439250
🔬NCT07439250Phase 1RECRUITING

A Study of Olomorasib (LY3537982) in Healthy Participants

Study Summary

The main purpose of this study in healthy participants is to determine the effect of fluconazole on the amount of study drug that gets into the bloodstream and how long it takes the body to get rid of it. For each participant, the study will last up to approximately 7 weeks and will require 12 overnight stays in the research center.

Conditions
Interventions / Drugs
View on ClinicalTrials.gov ↗
Study Details
Enrollment15 participants
Primary Completion
Lead SponsorEli Lilly and Company
Data Retrieved2026-04-11 02:55:33.867180+00:00
Not financial advice. BiotechSigns data is sourced from ClinicalTrials.gov, SEC EDGAR, and other public databases for research and informational purposes only. It does not constitute investment recommendations. Always do your own due diligence before making investment decisions.